Form 4 · Filed Jun 16, 2026, 08:21 PM UTC
FTH/Sensei Biotherapeutics, Inc.
Hahn Stephen M. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | C | other | 44,763 | — | — | 44,763 |
| Jun 15, 2026 | C | other | 45 | — | — | 0 |
| Jun 12, 2026 | A | other | 25,000 | — | — | 25,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0002137706-26-000003